15
Views
10
CrossRef citations to date
0
Altmetric
Original Article

The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man

Pages 367-379 | Received 19 Apr 1988, Accepted 20 Oct 1988, Published online: 08 Jul 2009

References

  • McIntyre N, Holdsworth C D, Turner D S. New interpretation of oral glucose tolerance. Lancet 1964; ii: 20–1
  • Unger R H, Eisentraut A M. Entero-insular axis. Arch Intern Med 1969; 123: 261–6
  • Creutzfeldt W, Ebert R. New developments in the incretin concept. Diabetologia 1985; 28: 565–73
  • Brown J C, Dryburgh J R, Ross S A, Dupre J. Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res 1975; 31: 487–532
  • Cataland S, Crockett S E, Brown J C, Mazzaferri E L. Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J Clin Endocrinol Metab 1974; 39: 223–8
  • Thomas F B, Mazzaferri E L, Crockett S E, Mekhjian H S, Gruemer H D, Cataland S. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology 1976; 70: 523–7
  • Duprè J, Ross S A, Watson D, Brown J C. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab 1973; 37: 826–8
  • Andersen D K, Elahi D, Brown J C, Tobin J D, Andres R. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 1978; 62: 152–61
  • Karam J H, Grodsky G M, Forsham P H. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 1963; 12: 197–204
  • DeFronzo R A, Ferrannini E, Koivisto V. New concepts in the pathogenesis and treatment of non-insulin-dependent diabetes mellitus. Am J Med 1983; 74: 52–81
  • DeFronzo R A. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095–101
  • Perley M J, Kipnis D M. Plasma insulin responses to oral and intravenous glucose. Studies in normal and diabetic subjects. J Clin Invest 1967; 46: 1954–62
  • Cerasi E, Efendic S, Luft R. Dose-response relation between plasma insulin and blood glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1973; i: 794–7
  • Crockett S E, Mazzaferri E L, Cataland S. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus. Diabetes 1976; 25: 931–5
  • Ebert R, Frerichs H, Creutzfeldt W. Serum gastric inhibitory polypeptide (GIP) response in patients with maturity-onset diabetes and in juvenile diabetics. Diabetologia 1976; 12: 388A
  • Bloom S R. GIP in diabetes. Diabetologia 1975; 11: 334A
  • Alam M J, Buchanan K D. Gastric inhibitory polypeptide (GIP) responses in diabetes using three different antibodies. Regul Pept 1980, Suppl. 1: 2
  • Service F J, Rizza R A, Westland R E, Hall L D, Gerich J E, Go V LW. Gastric inhibitory polypeptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 1984; 58: 1133–40
  • Sarson D L, Kopelman P G, Besterman H S, Pilk-Ington T RE, Bloom S R. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man. Diabetologia 1983; 25: 386–91
  • Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown J C. Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels. Diabetologia 1978; 14: 15–24
  • Elahi D, Andersen D K, Muller D C, Tobin J D, Brown J C, Andres R. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes 1984; 33: 950–7
  • Krarup T, Hoist J J, Knuthsen S, Moody A J, Nielsen O V. Effect of porcine 8000 dalton immunoreactive gastric inhibitory polypeptide on the isolated perfused pig pancreas. Diabetologia 1987; 30: 543 A
  • Krarup T, Hoist J J, Lindorff Larsen K. Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat. Am J Physiol 1985; 249: E195–E200
  • Fajans S S, Cloutier M C, Crowther R L. Clinical and etiologic heterogeneity of idiopathic diabetes mellitus. Diabetes 1978; 27: 1112–25
  • Groop L, Groop P H, Koskimies S. Relationship between B-cell function and HLA antigens in patients with Type 2 (non-insulin-dependent) diabetes. Diabetologia 1986; 29: 757–60
  • O'Sullivan J B, Mahan C M, Freedlender A E, Williams R F. Effect of age on carbohydrate metabolism. J Clin Endocrinol 1971; 33: 619–23
  • WHO Study Group. Diabetes mellitus. Geneva 1985, Technical Report Series 727
  • Groop P H, Fyhrquist F, Groop L C. Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls. Scand J Clin Lab Invest 1985; 45: 115–22
  • Heding L G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabeto-logia 1972; 8: 260–6
  • Heding L G. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8
  • Hunter W M, Greenwood F C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495–6
  • Knip M. Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography. Horm Metab Res 1984; 16: 487–91
  • Jörnwall H, Carlquist M, Kwauk S, Otte S C, McIntosh H S, Brown J C, Mutt V. Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Letters 1981; 123: 205–10
  • Dixon W J. BMDP Statistical Software. University of California Press, Berkeley 1985
  • Kramp T, Hoist J J. The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept 1984; 9: 35–46
  • Moody A J, Thim L, Valverde I. The isolation and sequencing of human gastric inhibitory polypeptide (GIP). FEBS Lett 1984; 172: 142–8
  • Verdonk C A, Rizza R A, Nelson R L, Go V LW, Gerich J E, Service F J. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function. J Clin Invest 1980; 65: 1119–25
  • MacGregor I L, Gueller R, Watts H D, Meyer J H. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70: 190–6
  • Palmer J P, Ensinck J W. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J Clin Endocrinol Metab 1975; 41: 498–503
  • Cerasi E, Luft R, Efendic J. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 1972; 21: 224–34
  • Ebert R, Creutzfeldt W. Hypo- and hypersecretion of GIP in maturity-onset diabetics. Diabetologia 1980; 19: 271–2A
  • Jones I R, Owens D R, Moody A J, Luzio S D, Morris T, Hayes T M. The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion. Diabetologia 1987; 30: 707–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.